Massachusetts Financial Services’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,044
| Closed | -$209K | – | 954 |
|
|
2021
Q3 | $209K | Sell |
1,044
-14
| -1% | -$2.8K | ﹤0.01% | 902 |
|
|
2021
Q2 | $270K | Buy |
1,058
+9
| +0.9% | +$2.3K | ﹤0.01% | 896 |
|
|
2021
Q1 | $278K | Sell |
1,049
-124
| -11% | -$32.9K | ﹤0.01% | 901 |
|
|
2020
Q4 | $432K | Sell |
1,173
-12
| -1% | -$4.42K | ﹤0.01% | 846 |
|
|
2020
Q3 | $289K | Buy |
+1,185
| New | +$289K | ﹤0.01% | 850 |
|